Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea

JAMA - Journal of the American Medical Association

Volumn 313, Issue 16, 2015, Pages 1671-1672

  Stettler, Nicolas ^a   McKiernan, Colleen M ^a   Melin, Court Q ^a   Adejoro, Oluwakayode O ^a   Walczak, Nancy B ^a  

^a LEWIN GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; ANTISICKLING AGENT;

ACUTE CHEST SYNDROME; ADULT; DRUG INDICATION; EMERGENCY WARD; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; ICD-9; LETTER; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PAIN; PRESCRIPTION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; THORAX PAIN; YOUNG ADULT; ANEMIA, SICKLE CELL; CLINICAL PRACTICE; COMPLICATION; FACTUAL DATABASE; INSURANCE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; DATABASES, FACTUAL; FEMALE; HUMANS; HYDROXYUREA; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; PAIN; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 84928718664     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.3075     Document Type: Letter

References (5)

1. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033-1048.
2. Brawley OW, Cornelius LJ, Edwards LR, et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008;148(12):932-938.
3. Lanzkron S, Strouse JJ, Wilson R, et al. Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med. 2008;148(12): 939-955.
4. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care. 2013;36(4):1033-1046.
5. Burke JP, Jain A, Yang W, et al. Does a claims diagnosis of autism mean a true case? Autism. 2014;18(3):321-330.